Cambridge Healthtech Institute’s 9th Annual

Degraders & Molecular Glues – Part 2

Pursuing Challenging Drug Targets, Exploring New Ligases and Degradation Pathways

April 15 - 16, 2026 ALL TIMES PDT

Bi-functional degraders like Proteolysis-targeting chimeras (PROTACs), monovalent degraders like molecular glues and other emerging degrader modalities are being used to hijack the ubiquitin-proteasome, lysosome, and autophagy systems for targeted protein degradation. They are seeking out previously “undruggable” targets for therapeutic intervention by exploring novel chemistries and chemical spaces and using innovative assays and screening tools to better understand and predict complex cellular interactions. This two-part conference on Degraders & Molecular Glues brings together experts in the field to discuss opportunities and challenges involved in pursuing targeted degradation and induced proximity as viable therapeutic strategies.
6:15 pm WEDNESDAY, APRIL 15: Recommended Dinner Short Course*
SC5: Protein Degraders: An in vivo ADME and Safety Perspective

*Premium Pricing or separate registration required. See Short Courses page for details.





Failed to load agenda from https://api.speakers.healthtech.com/api/agenda/new/UBQ2264306/final: The remote server returned an error: (500) Internal Server Error.

For more details on the conference, please contact:
Tanuja Koppal, PhD
Senior Conference Director
Cambridge Healthtech Institute
Email: tkoppal@healthtech.com

For sponsorship information, please contact:
Kristin Skahan
Senior Business Development Manager
Cambridge Healthtech Institute
Phone: (+1) 781-972-5431
Email: kskahan@healthtech.com